Tocqueville Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-20,016
Closed -$2.75M 537
2024
Q2
$2.75M Hold
20,016
0.05% 234
2024
Q1
$2.75M Sell
20,016
-145
-0.7% -$19.8K 0.04% 240
2023
Q4
$2.74M Buy
20,161
+145
+0.7% +$17.7K 0.05% 228
2023
Q3
$2.45M Hold
20,016
0.05% 237
2023
Q2
$2.54M Hold
20,016
0.05% 242
2023
Q1
$2.59M Sell
20,016
-46
-0.2% -$6.02K 0.05% 246
2022
Q4
$2.63M Buy
20,062
+46
+0.2% +$5.95K 0.05% 253
2022
Q3
$2.34M Hold
20,016
0.05% 264
2022
Q2
$2.35M Sell
20,016
-229
-1% -$27.2K 0.04% 295
2022
Q1
$2.64M Sell
20,245
-11,049
-35% -$1.44M 0.04% 313
2021
Q4
$4.78M Sell
31,294
-288
-0.9% -$44.6K 0.07% 257
2021
Q3
$5.11M Sell
31,582
-7,586
-19% -$1.28M 0.08% 244
2021
Q2
$6.41M Buy
39,168
+873
+2% +$134K 0.09% 228
2021
Q1
$5.77M Buy
38,295
+1,344
+4% +$213K 0.09% 235
2020
Q4
$5.6M Buy
36,951
+1,160
+3% +$166K 0.09% 222
2020
Q3
$4.85M Sell
35,791
-375
-1% -$50.9K 0.09% 205
2020
Q2
$4.94M Buy
36,166
+25
+0.1% +$3.19K 0.1% 198
2020
Q1
$3.89M Buy
36,141
+16,141
+81% +$1.86M 0.1% 199
2019
Q4
$2.41M Buy
+20,000
New +$2.23M 0.04% 337

Other funds holding IBB

Tocqueville Asset Management's IBB Position: Q3 2024 in Review

Tocqueville Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 20,016 shares — an estimated $2.75M sold.

Tocqueville Asset Management first reported a position in IBB in Q4 2019 and held it in 19 quarters. The position peaked at $6.41M in Q2 2021. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • Tocqueville Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
  • Tocqueville Asset Management sold 20,016 iShares Biotechnology ETF shares in Q3 2024, an estimated $2.75M.
  • Tocqueville Asset Management first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 19 quarters.
  • Tocqueville Asset Management's iShares Biotechnology ETF position peaked at $6.41M in Q2 2021.
  • 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Tocqueville Asset Management's 13F filing for Q3 2024, filed 8 Nov 2024.